| Previous Close | 82.190 |
| Open | 81.570 |
| Bid | 81.610 x 500 |
| Ask | 81.620 x 300 |
| Day's Range | 81.035 - 81.830 |
| 52 Week Range | 64.180 - 86.720 |
| Volume | 5,716,144 |
| Avg. Volume | 3,610,963 |
| Market Cap | 85.96B |
| Beta | 0.17 |
| PE Ratio (TTM) | 39.51 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 2.08 (2.45%) |
| Ex-Dividend Date | 2017-08-11 |
| 1y Target Est | N/A |
- Thomson Reuters StreetEvents•4 hours ago
Edited Transcript of LLY earnings conference call or presentation 25-Jul-17 1:00pm GMT
Q2 2017 Eli Lilly and Co Earnings Call
- Barrons.com•4 hours ago
Eli Lilly: The Competition is Just Too Darn Intense!
Yesterday, shares fop Eli Lilly (LLY) dropped 3% after the pharmaceutical giant beat earnings forecasts but said that a new drug application for a rheumatoid arthritis treatment had been delayed. Leerink ...
- Benzinga•4 hours ago
Zoetis Investors May Need Patience To See Bull Thesis Play Out
After a more than 15-percent gain in Zoetis Inc (NYSE: ZTS ) since the start of 2017, analysts at Deutsche Bank see little incremental upside in the near-term. Gregg Gilbert downgraded Zoetis' stock from ...
